| |
 |
|
Class Information
Number: 514/8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Glycoprotein (carbohydrate containing)
Description: Subject matter which contains a carbohydrate or derivative thereof attached to the peptide.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5856298 |
Erythropoietin isoforms |
Jan. 5, 1999 |
| 5856299 |
Highly reactive esters of carboxy polysaccharides and carboxy polysaccharides derived therefrom |
Jan. 5, 1999 |
| 5856300 |
Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
Jan. 5, 1999 |
| 5853728 |
Polyphenolic cosmetic composition |
Dec. 29, 1998 |
| 5854028 |
Compositions comprising IL-11 and methods of making and using IL-11 |
Dec. 29, 1998 |
| 5854069 |
GD2 anti-idiotypic antibodies and uses thereof |
Dec. 29, 1998 |
| 5854211 |
Compounds with growth hormone releasing properties |
Dec. 29, 1998 |
| 5851989 |
Method of extending the plasma half-life of vascular endothelial cell growth factor |
Dec. 22, 1998 |
| 5851993 |
Suppression of tumor cell growth by syndecan-1 ectodomain |
Dec. 22, 1998 |
| 5851997 |
Use of human chorionic gonadotropin as an immune-potentiating antiviral agent |
Dec. 22, 1998 |
| 5849283 |
Human interleukin-6 receptor antagonists |
Dec. 15, 1998 |
| 5849298 |
Treatment of multiple sclerosis by oral administration of bovine myelin |
Dec. 15, 1998 |
| 5849536 |
Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same |
Dec. 15, 1998 |
| 5849686 |
Morphogen-induced liver regeneration |
Dec. 15, 1998 |
| 5849689 |
Method of extending the plasma half-life of deletion variants of hepatocyte growth factor |
Dec. 15, 1998 |
| 5849702 |
Cloning and production of human von Willebrand factor GPIB binding domain polypeptides and methods of using same |
Dec. 15, 1998 |
| 5846757 |
Human calcium channel .alpha..sub.1, .alpha..sub.2, and .beta. subunits and assays using them |
Dec. 8, 1998 |
| 5846931 |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide and methods of inducing cartilage by administration of same |
Dec. 8, 1998 |
| 5846952 |
Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine drug delivery |
Dec. 8, 1998 |
| 5843445 |
Method of treating rheumatoid arthritis with type II collagen |
Dec. 1, 1998 |
| 5843451 |
Intranasal immunization against viral infection using viral glycoprotein subunit vaccine |
Dec. 1, 1998 |
| 5843705 |
Transgenically produced antithrombin III |
Dec. 1, 1998 |
| 5843775 |
Human dorsal tissue affecting factor (noggin) and nucleic acids encoding same |
Dec. 1, 1998 |
| 5843882 |
Antiviral proteins and peptides |
Dec. 1, 1998 |
| 5843883 |
Methods of wound healing and treating hyperproliferative diseases of epidermis comprising administering trunicated keratinocyte growh factor (KGF) having increased biological activity |
Dec. 1, 1998 |
| 5843889 |
Glycopeptide antibiotic derivatives |
Dec. 1, 1998 |
| 5843893 |
Method for inhibiting the proliferation of epithelial lens cells and implantable lens therefor |
Dec. 1, 1998 |
| 5840054 |
Method for obstructing lacrimal canaliculi with infusable solution or dispersion |
Nov. 24, 1998 |
| 5840681 |
X-ray induced skin damage protective composition |
Nov. 24, 1998 |
| 5840684 |
Glycopeptide antibiotic derivatives |
Nov. 24, 1998 |
| 5840686 |
Pigment epithelium-derived factor: characterization of its novel biological activity and sequences encoding and expressing the protein and methods of use |
Nov. 24, 1998 |
| 5840771 |
Prophylaxis against diseases tramsmittable by sexual contact, and therapy of such diseases |
Nov. 24, 1998 |
| 5837229 |
Uses of recombinant colony stimulating factor-1 |
Nov. 17, 1998 |
| 5837230 |
Methods of treating allergies with M-CSF |
Nov. 17, 1998 |
| 5837488 |
Cloning and production of human von Willebrand Factor GP1b binding domain polypeptides and methods of using same |
Nov. 17, 1998 |
| 5837675 |
Synergistic effect of insulin-like growth factor-I and erythropoietin |
Nov. 17, 1998 |
| 5837676 |
Use of scatter factor to enhance angiogenesis |
Nov. 17, 1998 |
| 5837679 |
Agents affecting thrombosis and hemostasis |
Nov. 17, 1998 |
| 5834419 |
Chemokine binding protein and methods of use therefor |
Nov. 10, 1998 |
| 5834423 |
Pharmaceutical composition containing sialic acid derivatives |
Nov. 10, 1998 |
| 5834424 |
Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus |
Nov. 10, 1998 |
| 5834435 |
Inhibition of TNF-.alpha. pleiotropic and cytotoxic effects |
Nov. 10, 1998 |
| 5830708 |
Methods for production of a naturally secreted extracellular matrix |
Nov. 3, 1998 |
| 5830847 |
Soluble TGF-.beta.-binding endoglin polypeptides and homodimers |
Nov. 3, 1998 |
| 5830851 |
Methods of administering peptides that bind to the erythropoietin receptor |
Nov. 3, 1998 |
| 5824648 |
Rnase-cv (coriolus versicolor) |
Oct. 20, 1998 |
| 5820863 |
Methods of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
Oct. 13, 1998 |
| 5821220 |
Method of producing concentrated non-buffered solutions of fibronectin |
Oct. 13, 1998 |
| 5821225 |
Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp |
Oct. 13, 1998 |
| 5821227 |
Modulators of cytokines of the tgf .beta. superfamily |
Oct. 13, 1998 |
|
|
|
